Health Care: Drugs

Neostem Inc. (NBS: AMEX)

$0.58 0.00 | 0.87%
05/22/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 14.33M 73.72M 69.82M 11.57M
Cost of Sales 8.79M 44.56M 44.25M 7.01M
Gross Operating Profit 5.54M 29.16M 25.57M 4.55M
Selling, General, and Administrative Expenses 22.32M 41.85M 31.35M 23.46M
Research & Development 10.45M 11.00M 7.68M 4.32M
Operating Income before D & A (EBITDA) -27.23M -23.69M -13.46M -23.22M
Depreciation & Amortization 3.16M 11.42M 5.42M 577.04K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -4.31M 2.34M 513.11K 52.07K
Special Income / Charges 0.00 -19.43M 0.00 0.00
Total Income Before Interest Expenses (EBIT) -34.70M -52.20M -18.37M -23.75M
Interest Expense 1.58M 3.99M 480.90K 91.26K
Pre-Tax Income -36.28M -56.19M -18.85M -23.84M
Income Taxes -175.53K 392.77K 550.91K 344.20K
Minority Interest -12.60M -9.45M 3.91M 1.09M
Net Income From Continuing Operations -36.10M 0.00 0.00 0.00
Net Income From Discontinued Operations -30.27M 0.00 0.00 0.00
Net Income From Total Operations -66.37M 0.00 0.00 0.00
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -53.77M -47.13M -23.31M -25.27M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -36.10M 19.43M 0.00 0.00
Preferred Dividends
Net Income Available To Common -36.63M -639.76K -237.96K -5.61M
Basic EPS from Continuing Ops. -0.26 -0.54 -0.46 -2.37
Basic EPS from Discontinued Ops. -0.13 0.00 0.00 0.00
Basic EPS from Total Operations -0.39 -0.54 -0.46 -2.37
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) -0.01 0.00 0.00 0.00
Basic EPS, Total -0.40 -0.54 -0.46 -2.37
Basic Normalized Net Income/Share -0.26 n.a. n.a. n.a.
EPS fr Continuing Ops. -0.26 -0.54 -0.46 -2.37
EPS fr Discontinued Ops -0.13 0.00 0.00 0.00
EPS fr Total Ops. -0.39 -0.54 -0.46 -2.37
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) -0.01 0.00 0.00 0.00
EPS, Total -0.40 -0.54 -0.46 -2.37
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -0.26 n.a. n.a. n.a.
Dividends Paid per Share 0.00 0.04 0.00 0.00

Portfolios with NBS

View All

Latest NBS Headlines from TheStreet

More Financial News for NBS

Press Releases for NBS

See All Press Releases

Partner Headlines for NBS

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter